RECRUITING

Constraint Induced Movement Therapy for Walking in Individuals Post Stroke

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.

Official Title

Constraint Induced Movement Therapy for Walking in Individuals Post Stroke

Quick Facts

Study Start:2017-08-14
Study Completion:2024-10-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03264261

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. age between 21 and 75 years;
  2. 2. history of unilateral, supratentorial, ischemic or hemorrhagic stroke;
  3. 3. no prior stroke;
  4. 4. demonstration of impaired walking function (self-selected walking speed ≤ 0.80 m/s);
  5. 5. able to stand and walk (\>10 meters) without physical assistance.
  1. 1. significant cardiorespiratory/metabolic disease;
  2. 2. other neurological or orthopedic injury that impairs locomotion;
  3. 3. scores on the Mini Mental Status examination \< 24;
  4. 4. stroke of the brainstem or cerebellar lesions;
  5. 5. uncontrolled hypertension (systolic \> 200 mm Hg, diastolic \> 110 mm Hg);
  6. 6. botox injection within 6 months of starting the study.

Contacts and Locations

Study Contact

Weena Dee, PT
CONTACT
312-238-7503
wdee@ric.org

Principal Investigator

Ming Wu, PhD
PRINCIPAL_INVESTIGATOR
Abilitylab

Study Locations (Sites)

Abilitylab
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Shirley Ryan AbilityLab

  • Ming Wu, PhD, PRINCIPAL_INVESTIGATOR, Abilitylab

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-08-14
Study Completion Date2024-10-30

Study Record Updates

Study Start Date2017-08-14
Study Completion Date2024-10-30

Terms related to this study

Keywords Provided by Researchers

  • stroke, locomotion

Additional Relevant MeSH Terms

  • Stroke